Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients
<p>ABSTRACT</p> <p>Background</p> <p>Treatment with selective vitamin D receptor activators such as paricalcitol have been shown to exert an anti-inflammatory effect in patients on hemodialysis, in addition to their action on mineral metabolism and independently of parathyroid hormone (PTH) levels....
Salvato in:
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMC
2012-11-01
|
| Serie: | BMC Nephrology |
| Soggetti: | |
| Accesso online: | http://www.biomedcentral.com/1471-2369/13/159 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|